Radx tech - visby medical INC. For single-use (DISPOSABLE), fully-integrated, rapid, automated RT-PCR in vitro diagnostic test
Ended Definitive Contract Awarded Last action
- Contract number
- 75N92020C00012
- Awardee
-
Visby Medical, Inc. UEI LWNQZECSVHY1
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $9,498,805
Award facts
- Contract value 100% obligated
- $9,498,805.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- San Jose, CA 95134, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Other Administrative Action | -$124,984 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $9,623,789 |
About this award
Visby Medical, Inc. was awarded a definitive contract valued at $9.5 million by the National Institutes of Health's National Heart Lung and Blood Institute to deliver a single-use, fully-integrated, rapid, automated reverse transcription polymerase chain reaction in vitro diagnostic test. The contract is associated with the Rapid Acceleration of Diagnostics program and will support Visby Medical's development and delivery of its rapid point-of-care COVID-19 diagnostic test. Work will be performed by Visby Medical in San Jose, California over a two-year period under a firm fixed-price arrangement. This award to a prime contractor furthers the National Institutes of Health's efforts to accelerate the availability of diagnostic technologies critical to responding to the COVID-19 pandemic.
Quick answers
Who was awarded contract 75N92020C00012?
75N92020C00012 was awarded to Visby Medical, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on September 29, 2020.
How much is contract 75N92020C00012 worth?
The government has obligated $9,498,805 on 75N92020C00012.
Was contract 75N92020C00012 competed?
The extent of competition for 75N92020C00012 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award